Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F74JM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,678
Award facts
- Contract value 100% obligated
- $18,678.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,678.32 on February 2, 2026, for the supply of RINVOQ ER 30 MG tablets (30-count units). This non-competitive, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA) and represents a direct fulfillment of pharmaceutical needs for the military healthcare supply chain. The award carries an ultimate completion date of February 3, 2026, indicating expedited delivery requirements typical of medical procurement for active defense operations or urgent inventory replenishment.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio and demonstrated capacity to deliver critical medical commodities across multiple therapeutic domains position the company as a key vendor supporting Defense Health Agency operations and military treatment facilities globally.
Quick answers
Who was awarded contract SPE2DR26F74JM?
SPE2DR26F74JM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26F74JM worth?
The government has obligated $18,678 on SPE2DR26F74JM.
Is contract SPE2DR26F74JM an order under another contract?
Yes. SPE2DR26F74JM is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F74JM competed?
The extent of competition for SPE2DR26F74JM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award